RT Journal Article
SR Electronic
T1 Uncertainty quantification and sensitivity analysis of COVID-19 exit strategies in an individual-based transmission model
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.24.21254218
DO 10.1101/2021.03.24.21254218
A1 Gugole, Federica
A1 Coffeng, Luc E.
A1 Edeling, Wouter
A1 Sanderse, Benjamin
A1 Vlas, Sake J. de
A1 Crommelin, Daan
YR 2021
UL http://medrxiv.org/content/early/2021/03/26/2021.03.24.21254218.abstract
AB Many countries are currently dealing with the COVID-19 epidemic and are searching for an exit strategy such that life in society can return to normal. To support this search, computational models are used to predict the spread of the virus and to assess the efficacy of policy measures before actual implementation. The model output has to be interpreted carefully though, as computational models are subject to uncertainties. These can stem from, e.g., limited knowledge about input parameters values or from the intrinsic stochastic nature of some computational models. They lead to uncertainties in the model predictions, raising the question what distribution of values the model produces for key indicators of the severity of the epidemic. Here we show how to tackle this question using techniques for uncertainty quantification and sensitivity analysis.We assess the uncertainties and sensitivities of four exit strategies implemented in an agent-based transmission model with geographical stratification. The exit strategies are termed Flattening the Curve, Contact Tracing, Intermittent Lockdown and Phased Opening. We consider two key indicators of the ability of exit strategies to avoid catastrophic health care overload: the maximum number of prevalent cases in intensive care (IC), and the total number of IC patient-days in excess of IC bed capacity. Our results show that uncertainties not directly related to the exit strategies are secondary, although they should still be considered in comprehensive analysis intended to inform policy makers. The sensitivity analysis discloses the crucial role of the intervention uptake by the population and of the capability to trace infected individuals. Finally, we explore the existence of a safe operating space. For Intermittent Lockdown we find only a small region in the model parameter space where the key indicators of the model stay within safe bounds, whereas this region is larger for the other exit strategies.Author summary Many countries are currently dealing with the COVID-19 epidemic and are looking for an exit strategy such that life in society can return to normal. For that purpose computational models are used to predict the spread of the virus and to assess the efficacy of policy measures before putting them into practice. These models are subject to uncertainties (due to, for instance, limited knowledge of the parameter values), which can lead to a large variability in model predictions. It is therefore fundamental to assess which range of values a model produces for key indicators of the severity of the epidemic.We present here the results of the uncertainty and sensitivity analysis of four exit strategies simulated with an individual-based model of the COVID-19 transmission. As key indicators of the severity of the pandemic we consider the maximum number of cases in intensive care and the total number of intensive care patient-days in excess. Our results show the crucial role of the intervention uptake by the population, of the reduction in the level of transmission by intervention and of the capability to trace infected individuals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFG, WE and DC were supported by the European Union Horizon 2020 research and innovation program under grant agreement #800925 (VECMA project). The calculations were performed at the Poznan Supercomputing and Networking Center. LEC acknowledges funding from the Dutch Research Council (NWO, grant 016.Veni.178.023). LEC, SJdV and DC received support from ZonMw grant #10430022010001.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB or ethics committee approval was necessary for this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe transmission model considered in the analysis is publicly available on GitLab. The scripts used for the execution of the UQ and SA campaigns and post-processing analysis are publicly available on GitHub. All data considered in this study have been generated by the aforementioned scripts and computational model. https://gitlab.com/luccoffeng/virsim/-/tree/v1.0.5 https://github.com/FGugole/UQ_covid19/tree/master/EasyVVUQ